Carbocyclic thromboxane A2 enhances the angiotensin II-induced DNA synthesis in smooth muscle cells

European Journal of Pharmacology

Volumn 307, Issue 1, 1996, Pages 121-124

  Sachinidis, Agapios ^a   El Haschimi, Karim ^a   Ko, Yon ^a   Seul, Claudia ^a   Epping, Petra ^a   Vetter, Hans ^a  

^a UNIVERSITY HOSPITAL BONN   (Germany)

Author keywords

Angiotensin II; c fos; Smooth muscle cell; Thromboxane A2

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; CANDESARTAN; CANDESARTAN HEXETIL; CARBOCYCLIC THROMBOXANE A2; DRUG METABOLITE; MESSENGER RNA; PROTEIN C FOS; RADIOISOTOPE; THYMIDINE; ANGIOTENSIN II; ANTIHYPERTENSIVE AGENT; ANTITHROMBOCYTIC AGENT; BENZIMIDAZOLE DERIVATIVE; BIPHENYL DERIVATIVE; DNA; DRUG DERIVATIVE; TETRAZOLE DERIVATIVE; THROMBOXANE A2; THROMBOXANE A2, CARBOCYCLIC; VASOCONSTRICTOR AGENT;

ANIMAL CELL; ARTICLE; CELL COUNT; CELL PROLIFERATION; CONTROLLED STUDY; DNA SYNTHESIS; DRUG ANTAGONISM; DRUG POTENTIATION; NONHUMAN; PRIORITY JOURNAL; RAT; SMOOTH MUSCLE FIBER; THORACIC AORTA; VASCULAR SMOOTH MUSCLE; ANIMAL; BIOSYNTHESIS; CELL CULTURE; CELL DIVISION; DRUG EFFECT; METABOLISM; PHYSIOLOGY; WISTAR KYOTO RAT;

ANGIOTENSIN II; ANIMALS; ANTIHYPERTENSIVE AGENTS; BENZIMIDAZOLES; BIPHENYL COMPOUNDS; CELL DIVISION; CELLS, CULTURED; DNA; MUSCLE, SMOOTH, VASCULAR; PLATELET AGGREGATION INHIBITORS; PROTO-ONCOGENE PROTEINS C-FOS; RATS; RATS, INBRED WKY; RNA, MESSENGER; TETRAZOLES; THROMBOXANE A2; VASOCONSTRICTOR AGENTS;

EID: 0030594563     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/0014-2999(96)00282-8     Document Type: Article

References (13)

1. Campbell, D.J., 1986, Circulating and tissue angiotensin system, J. Clin. Invest. 79, 1.
2. Campbell, J.H. and R.G. Campbell, 1993, Culture techniques and their applications to studies of vascular smooth muscle, Clin. Sci. 85, 501.
3. Chamley, J.H., G.R. Cambell and R. Ross, 1979, The smooth muscle cell in culture, Physiol. Rev. 39, 1.
4. Chirgwin, J.J., R.J. Przybyla, R.J. MacDonald and W.J. Rutter, 1979, Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease, Biochemistry 18, 5294.
5. Fitzgerald, D.J., L. Roy, F. Catella and G.A. Fitzgerald, 1986, Platelet activation in unstable coronary disease. New Engl. J. Med. 315, 983.
6. Flesch, M., Y. Ko, C. Seul, R. Düsing, H. Feltkamp, H. Vetter and A. Sachinidis, 1995, Effects of TCV-116 and CV-11974 on angiotensin II-induced responses in vascular smooth muscle cells, Eur. J. Pharmacol. 289, 399.
7. 2 receptor agonist, J. Pharmacol. Exp. Ther. 251, 557.
8. 2 and vascular smooth muscle cell proliferation, Hypertension 26, 771.
9. Schwartz, S.M. and M. Reidy, 1987, Common mechanisms of proliferation of smooth muscle in atherosclerosis and hypertension, Hum. Pathol. 8, 240.
10. Schwartz, S.M, G.R. Campbell and J.H. Campbell, 1986, Replication of smooth muscle cells in vascular disease, Circ. Res. 58, 427.
11. 2, Am. J. Physiol. 240, H493.
12. Taubman, M.B., B.C. Berk, S. Izumo, T. Tsuda, R.W. Alexander and B. Nadal-Ginard, 1989, Angiotensin II induces c-fos mRNA in aortic smooth muscle, J. Biol. Chem. 264, 526.
13. Verma, I.M. and P. Sassonc-Corsi, 1987, Proto-oncogene fos: complex but versatile regulation, Cell 51, 513.